Cite
HARVARD Citation
Bachy, E. et al. (2022). Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA). Journal of clinical oncology. 40 (3), pp. 242-251. [Online].